With star checkpoint inhibitors like Keytruda and Opdivo now sporting subcutaneous formulations, GSK has struck a deal aimed ...

After a series of headcount reductions in recent years, Takeda has disclosed a new round of cuts expected to affect ...

The “Rerouting Minds” webpage comprises information about LSD’s clinical history dating back to the 1930s, about how ...

The U.S. Supreme Court has decided to hear a case between Amarin Pharma and generic drugmaker Hikma that puts so-called ...

With an FDA accelerated approval in November 2023, Ixchiq became the world’s first shot for chikungunya. Its retreat leaves Bavarian Nordic’s Vimkunya the only available chikungunya vaccine in the U.S ...

The New York powerhouse has agreed to surrender its 11.7% interest in the HIV-focused company for $1.875 billion. Under terms ...

As the U.S. government intensifies efforts to acquire Greenland, President Donald Trump has responded to European pushback ...

Prefilled drug delivery device specialist Apiject has signed a lease for a new site in Apex, North Carolina, that will house ...

Amid a viral social media trend glorifying the halcyon days of 2016, Novo Nordisk has gone back an extra decade to find ...

Roughly half a year after breaking ground on the project, Roche is significantly upscaling its investment in a new production plant slated to come online in North Carolina’s biopharma hotbed. | Roche ...

Demonstrating value has become one of the biggest challenges facing life sciences companies, as payers and health technology ...

Friday afternoon, the company and its partner Genmab shared word that the phase 3 Epcore DLBCL-1 trial missed on its primary ...